Phoebe Mounts Esq.
Net Worth
Last updated:
What is Phoebe Mounts Esq. net worth?
The estimated net worth of Dr. Phoebe Mounts Esq. is at least $3,232,512 as of 13 Aug 2020. He owns shares worth $94,032 as insider and has received compensation worth at least $3,138,480 in CorMedix Inc..
What is the salary of Phoebe Mounts Esq.?
Dr. Phoebe Mounts Esq. salary is $523,080 per year as Executive Vice President, Gen. Counsel, Sec. and Head of Regulatory, Compliance & Legal in CorMedix Inc..
How old is Phoebe Mounts Esq.?
Dr. Phoebe Mounts Esq. is 75 years old, born in 1950.
What stocks does Phoebe Mounts Esq. currently own?
As insider, Dr. Phoebe Mounts Esq. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
CorMedix Inc. (CRMD) | Executive Vice President, Gen. Counsel, Sec. and Head of Regulatory, Compliance & Legal | 7,200 | $13.06 | $94,032 |
What does CorMedix Inc. do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Phoebe Mounts Esq. insider trading
CorMedix key executives
CorMedix Inc. executives and other stock owners filed with the SEC:
- Dr. Matthew T. David M.D. (47) Interim Chief Executive Officer, Executive Vice President & Chief Financial Officer
- Dr. Phoebe Mounts Esq. (75) Executive Vice President, Gen. Counsel, Sec. and Head of Regulatory, Compliance & Legal
- Ms. Elizabeth Masson-Hurlburt (46) Executive Vice President & Head of Clinical Operations